Consolidated Statements of Cash Flows (unaudited) - USD ($) $ in Thousands	3 Months Ended
	May 28, 2022	May 29, 2021
Operating Activities
Net earnings	$ 22,731	$ 10,817
Adjustments to reconcile net earnings to net cash (used) provided by operating activities:
Depreciation and amortization	10,849	12,980
Share-based compensation	1,597	1,674
Deferred income taxes	4,400	941
Gain on disposal of assets	(660)	(421)
Proceeds from New Markets Tax Credit transaction, net of deferred costs	18,390	0
Settlement of New Markets Tax Credit transaction	(19,523)	0
Noncash lease expense	3,088	3,098
Other, net	952	479
Changes in operating assets and liabilities:
Receivables	(26,671)	4,455
Inventories	(17,744)	2,252
Costs and earnings on contracts in excess of billings	(5,325)	1,205
Accounts payable and accrued expenses	(18,331)	(22,449)
Billings in excess of costs and earnings on uncompleted contracts	(2,152)	(6,434)
Refundable and accrued income taxes	4,238	1,410
Operating lease liability	(3,333)	(3,113)
Other, net	(2,968)	(11)
Net cash (used) provided by operating activities	(30,462)	6,883
Investing Activities
Capital expenditures	(5,125)	(4,705)
Proceeds from sales of property, plant and equipment	4,087	438
Other, net	100	119
Net cash used by investing activities	(938)	(4,148)
Financing Activities
Borrowings on line of credit	161,000	0
Repayment on debt	(1,000)	0
Payments on line of credit	(62,000)	0
Proceeds from exercise of stock options	0	4,115
Repurchase and retirement of common stock	(74,312)	(12,625)
Dividends paid	(4,793)	(5,035)
Other, net	(1,271)	(712)
Net cash provided (used) by financing activities	17,624	(14,257)
Decrease in cash, cash equivalents and restricted cash	(13,776)	(11,522)
Effect of exchange rates on cash	64	714
Cash, cash equivalents and restricted cash at beginning of year	37,583	47,277
Cash, cash equivalents and restricted cash at end of period	23,871	36,469
Noncash Activity
Capital expenditures in accounts payable	$ 766	$ 1,058